ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. C. 医薬保健学域; 医学類・薬学類・医薬科学類・保健学類
  2. c 10. 学術雑誌掲載論文(医・保健)
  3. 1. 査読済論文(医学・保健)

Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition

http://hdl.handle.net/2297/46747
http://hdl.handle.net/2297/46747
5d2f301e-a48d-47f3-9cb9-0a71300cbb81
名前 / ファイル ライセンス アクション
ME-PR-NAKAMURA-H-201.pdf ME-PR-NAKAMURA-H-201.pdf (733.6 kB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2017-10-03
タイトル
タイトル Loss of epidermal growth factor receptor expression in oral squamous cell carcinoma is associated with invasiveness and epithelial-mesenchymal transition
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_6501
資源タイプ journal article
著者 Kimura, Iyo

× Kimura, Iyo

WEKO 24560

Kimura, Iyo

Search repository
Kitahara, Hiroko

× Kitahara, Hiroko

WEKO 24561

Kitahara, Hiroko

Search repository
Ooi, Kazuhiro

× Ooi, Kazuhiro

WEKO 24562

Ooi, Kazuhiro

Search repository
Kato, Koroku

× Kato, Koroku

WEKO 24563
e-Rad 30444201

Kato, Koroku

Search repository
Noguchi, Natuyo

× Noguchi, Natuyo

WEKO 24564

Noguchi, Natuyo

Search repository
Yoshizawa, Kunio

× Yoshizawa, Kunio

WEKO 24565
e-Rad 60452108

Yoshizawa, Kunio

Search repository
Nakamura, Hiroyuki

× Nakamura, Hiroyuki

WEKO 24503
金沢大学研究者情報 30542253
研究者番号 30542253

Nakamura, Hiroyuki

Search repository
Kawashiri, Shuichi

× Kawashiri, Shuichi

WEKO 110
e-Rad 30291371
金沢大学研究者情報 30291371
研究者番号 30291371

Kawashiri, Shuichi

Search repository
書誌情報 Oncology Letters

巻 11, 号 1, p. 201-207, 発行日 2016-01-01
ISSN
収録物識別子タイプ ISSN
収録物識別子 1792-1074
DOI
関連タイプ isIdenticalTo
識別子タイプ DOI
関連識別子 10.3892/ol.2015.3833
出版者
出版者 Spandidos Publications
抄録
内容記述タイプ Abstract
内容記述 Inhibition of epidermal growth factor receptor (EGFR) signaling has emerged as a novel therapeutic strategy for the treatment of oral squamous cell carcinoma (OSCC). The EGFR-directed inhibitor cetuximab is currently the only approved targeted therapy for the treatment of OSCC. EGFR status may affect the patient response to cetuximab treatment. In the present study, via analysis of the immunomarker for EGFR, it was revealed that 58.3% of the total cases investigated stained positively for EGFR expression, and furthermore, that invasiveness was inversely correlated with EGFR expression. Expression levels of EGFR were quantified, and the correlation between EGFR expression and cetuximab sensitivity was investigated using three varying grades of invasive human OSCC line. EGFR expression in high-grade invasive cells was significantly downregulated compared with that of low-grade invasive cells. There was no significant antiproliferative effect in the high-grade invasive cells treated with various concentrations of cetuximab. The EMT-associated genes, N-cadherin, vimentin and Snail, were upregulated in the high-grade invasive cells. The low-grade invasive cells exhibited characteristics of typical epithelial cells, including the expression of E-cadherin and absence of the expression of N-cadherin, vimentin and Snail. Transforming growth factor-β induced low-grade invasive cells to undergo an epithelial-mesenchymal transition (EMT)-associated gene switch, which resulted in low levels of EGFR expression. The results of the present study suggested that loss of EGFR expression in OSCC was associated with EMT, and may have functional implications with regard to tumor invasiveness and the resistance to cetuximab treatment. © Spandidos Publications 2015. All rights reserved.
内容記述
内容記述タイプ Other
内容記述 Embargo Period 6 months
著者版フラグ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
戻る
0
views
See details
Views

Versions

Ver.1 2023-07-28 00:50:23.944587
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3